Vinesh R. Melvani

Vinesh Melvani practices at Dermatology Associates of La Grange in Lagrange, Illinois.

Vinesh Melvani's NPI, 1790199933, was assigned on June 16, 2014. Vinesh Melvani holds Illinois license 036153348.

Vinesh Melvani's primary practice is Dermatology Associates of La Grange, at 5201 S Willow Springs Rd- Suite 440, Lagrange, IL 60525. The practice phone is (708) 482-3213.

Vinesh Melvani's primary practice is Dermatology Associates of La Grange in Lagrange, Illinois. Vinesh Melvani is also affiliated with UChicago Medicine AdventHealth La Grange. The medical group on file is Dermatology Associates of La Grange. Dmand AI also links Vinesh Melvani to 1 more group practice or clinic, named with a free account. Vinesh Melvani's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Vinesh Melvani practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Vinesh Melvani's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Vinesh Melvani is licensed in Illinois.

CMS data shows 463 Medicare services from Vinesh Melvani across 8 procedure codes in 2024, for 174 Medicare patients. Medicare paid $26,365 for them. Every service was in an office.

CMS counts 174 Medicare patients who saw Vinesh Melvani in 2024. The largest group is 65 to 74, with 95 patients. 69% of them have high cholesterol, and 60% have high blood pressure. 22% are also on Medicaid. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Vinesh Melvani's median patient age at 55, with 42% women.

In 2024, Vinesh Melvani wrote 335 Medicare Part D claims for 124 patients. 90% of them were for generic drugs. CMS names the drug for 278 of them, across 7 drugs with 11 or more claims each, at $5,731 in total drug cost. In 2023, CMS named 133 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Vinesh Melvani for performance year 2024, reported through an alternative payment model (APM). Vinesh Melvani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 238 procedures of skin biopsy by Vinesh Melvani, more than 87% of the clinicians it reports for that procedure.

CMS Open Payments shows 19 general payments to Vinesh Melvani from 9 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $313.